Incomplete Nasolacrimal Duct Obstruction Drives Meibomian Gland Dysfunction in Postmenopausal PANDO

Overview

In postmenopausal women with primary acquired nasolacrimal duct obstruction (PANDO), incomplete obstruction is strongly associated with severe meibomian gland dysfunction (MGD), particularly upper eyelid gland loss and poorer lower eyelid meibum quality. This cross-sectional study highlights that obstruction severity, rather than demographic or hormonal factors, is the principal determinant of MGD in this population.

Background

Primary acquired nasolacrimal duct obstruction (PANDO) disrupts tear clearance, leading to ocular surface inflammation and damage. Meibomian glands (MGs) are essential for tear film stability, and their dysfunction (MGD) contributes to ocular surface disease. Postmenopausal women are particularly vulnerable due to hormonal changes and the high prevalence of PANDO. Understanding the factors driving MGD in PANDO is critical for improving clinical management and preserving ocular surface health.

Data Highlights

Key Findings

• Incomplete nasolacrimal duct obstruction is independently associated with severe upper eyelid meibomian gland loss (p < 0.001).
• Incomplete obstruction doubles the odds of poorer lower eyelid meibum quality (p = 0.019).
• Longer duration of PANDO correlates with decreased impairment in gland expressibility (p = 0.027).
• Higher non-invasive tear meniscus height predicts longer tear breakup time, indicating better tear film stability (p < 0.001).
• Demographic factors such as age and menopause duration, and serum hormone levels lose significance after multivariable adjustment.
• MGD in PANDO patients is often asymptomatic, underscoring the need for routine meibography.

Clinical Implications

Clinicians should recognize incomplete nasolacrimal duct obstruction as a key driver of meibomian gland dysfunction in postmenopausal women with PANDO. Routine meibography is recommended to detect subclinical gland atrophy, even in the absence of dryness symptoms, to guide timely ocular surface preservation strategies. Management should extend beyond addressing epiphora to include comprehensive ocular surface evaluation.

Conclusion

Incomplete PANDO is the principal factor associated with severe, often silent meibomian gland dysfunction in postmenopausal women. Incorporating routine gland imaging into clinical practice may improve detection and management of ocular surface disease in this population.

References

1. Wang et al. 2023 -- Association of Incomplete Nasolacrimal Duct Obstruction with Meibomian Gland Dysfunction in Postmenopausal Women Diagnosed with PANDO: A Cross-Sectional Analysis